Invention Grant
- Patent Title: Therapeutic peptides for the treatment of metastatic cancer
- Patent Title (中): 用于治疗转移性癌症的治疗肽
-
Application No.: US11404959Application Date: 2006-04-17
-
Publication No.: US07767642B2Publication Date: 2010-08-03
- Inventor: Joyce A. Schroeder
- Applicant: Joyce A. Schroeder
- Applicant Address: US AZ Pheonix
- Assignee: Arizona Biomedical Research Commission
- Current Assignee: Arizona Biomedical Research Commission
- Current Assignee Address: US AZ Pheonix
- Agency: Banner & Witcoff, Ltd.
- Main IPC: A61K38/17
- IPC: A61K38/17
Abstract:
Interaction between MUC1 and β-catenin can be interrupted using polypeptides or antibodies that specifically bind to the binding site on MUC1. Interruption provides the beneficial effect of inhibiting, reducing, and/or retarding invasiveness and metastasis. Fusion polypeptides and antibodies are provided to achieve a therapeutic effect.
Public/Granted literature
- US20060293234A1 Therapeutic peptides for the treatment of metastatic cancer Public/Granted day:2006-12-28
Information query
IPC分类:
